UNC Lineberger Comprehensive Cancer Center: Prostatic Neoplasms trials

The registry lists 17 Prostatic Neoplasms studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 5No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation OncologyRecruitingNCT07463833Not applicable
• Designing Visual Tools to Enhance Cancer Surgeon Decision-makingRecruitingNCT06965192Not applicable
• Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramCompletedNCT04350788Not applicableResults posted
• PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyTerminatedNCT04176497Phase 2Results posted
• Home-based Exercise Intervention for Patients With Metastatic Prostate CancerCompletedNCT03672396Not applicableResults posted
• Efficacy of a Couple-Focused mHealth Symptom Self-management ProgramCompletedNCT03489057Not applicableResults posted
• North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)CompletedNCT02564120Results posted
• Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00246753Phase 2Results posted
• Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate CancerCompletedNCT00225420Phase 1/2Results posted
• Physical Function During ARSI TreatmentCompletedNCT05612880
• PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerWithdrawnNCT04243941Phase 2
• Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate CancerTerminatedNCT02139774
• Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or EnzalutamideWithdrawnNCT02130947Not applicable
• Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT02008058
• Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyCompletedNCT02003417
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNCT00073970Phase 2
• Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate CancerWithdrawnNCT00005827Phase 1